NDF Research

Latest news and analysis on NDF Research

Anatara Lifesciences ​- A good gut feeling

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Alcidion - Making hospitals smarter with Clinical Decision Support

ALC
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Sirtex Medical - If you can keep your head, when all about you are losing theirs...

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Resonance Health - World-leading MRI diagnostics

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Admedus - DNA vaccine Blue Sky, plus a growing core business

AHZ
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

LBT Innovations - Great new biotech productivity tool, potential company maker

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Dimerix - Favourable interim data with DMX-200

DXB
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Osprey gets ready to take off again

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

SomnoMed - An innovator's dillemma

SOM
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Innate Immunotherapeutics - An MS drug candidate where the patients are saying good things

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

PolyNovo - CSIRO-developed technology hits the big time

PNV
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Bionomics' new drug that the world is likely to pay attention to

BNO
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Viralytics - The Steel City's valuable contribution to defeating cancer

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Mayne Pharma - Emerging world leader in generic drugs

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Nanosonics makes it into the black as our latest billion dollar Life Sciences success story

NAN
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Boom times for AFT Pharmaceuticals

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Monoclonal antibodies are a >US$70bn drug class. This Aussie company is set to revolutionise that market

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Clinuvel - Proof that Australian companies can do world-class drug development

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Medical Developments - the big money is still to come

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

The amazing comeback of Reva Medical (ASX: RVA)

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research
21-40 of 47